60 Degrees Pharmaceuticals, Inc. (SXTP)

SXTP Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-1.57	-3.77	-6.18	-4.25	-3.03
Depreciation & Amortization	0.08	0.1	0.08	0.07	0.03
Other Amortization	0.03	0.74	1.16	0.6	0.43
Stock-Based Compensation	3.8	1.74	-	-	-
Other Operating Activities	-7.51	-3.76	0.56	0.03	-0.01
Change in Accounts Receivable	-0.17	-0.19	0.1	0.71	-0.66
Change in Inventory	0.25	0.21	0.01	0.31	0.19
Change in Accounts Payable	-0.39	-0.21	0.17	-0.84	0.8
Change in Other Net Operating Assets	-0.67	0.59	3.09	2.72	2.1
Operating Cash Flow	-6.15	-4.54	-1.01	-0.65	-0.17
Capital Expenditures	-0.15	-0.06	-	-0	-
Sale (Purchase) of Intangibles	-0.09	-0.06	-0.06	-0.03	-0.07
Investing Cash Flow	-0.23	-0.12	-0.06	-0.04	-0.07
Short-Term Debt Issued	-	0.25	0.19	-	-
Long-Term Debt Issued	-	0.65	1.11	0.68	0.43
Total Debt Issued	-	0.9	1.29	0.68	0.43
Short-Term Debt Repaid	-	-0.25	-	-	-
Long-Term Debt Repaid	-	-1.61	-	-0.07	-0.15
Total Debt Repaid	-1.61	-1.86	-	-0.07	-0.15
Net Debt Issued (Repaid)	-1.61	-0.96	1.29	0.61	0.28
Issuance of Common Stock	9.51	7.59	-	-	-
Other Financing Activities	-0.03	-0.15	-0.07	-	-
Financing Cash Flow	7.87	6.47	1.22	0.61	0.28
Foreign Exchange Rate Adjustments	0.06	0.06	-0	-0	-0.13
Net Cash Flow	1.56	1.88	0.15	-0.08	-0.1
Free Cash Flow	-6.29	-4.6	-1.01	-0.65	-0.17
Free Cash Flow Margin	-1426.16%	-1814.28%	-197.57%	-10.27%	-6.56%
Free Cash Flow Per Share	-9.03	-13.94	-5.12	-0.03	-
Cash Interest Paid	0.18	0.18	0	-	-
Cash Income Tax Paid	0	0	0	0	0
Levered Free Cash Flow	-1.06	-6.22	-0.19	-1.7	-
Unlevered Free Cash Flow	-1.06	-5.53	1.14	-0.32	-
Change in Net Working Capital	-0.88	4.03	-2.22	-0.35	-

Source: S&P Capital IQ. Standard template. Financial Sources.